4D Pharma results disappoint markets
Shares in AIM-listed drug firm 4D Pharma dropped by 13.68% to 45.75p after it reported a post-tax loss of £23.7 million for the year ended 31st December.
Shares in AIM-listed drug firm 4D Pharma dropped by 13.68% to 45.75p after it reported a post-tax loss of £23.7 million for the year ended 31st December.
Trifast is an important supplier into significant parts of the global manufacturing process and its shares are undervalued, writes Mark Watson-Mitchell.
Simon Cawkwell, AKA Evil Knievil, with his latest trading and gambling exploits – writing exclusively for Master Investor.
Simon Cawkwell, AKA Evil Knievil, with his latest trading and gambling exploits – writing exclusively for Master Investor.
The price of shares in FTSE 100 fashion house Burberry climbed by 4.91% despite the firm reporting a 57% fall in operating profits for the year ended 28th March.
FTSE 250 travel firm Go-Ahead Group saw its share price plunge by 10.20% as it posted an update on current trading.
Shares in AIM-listed explorer Regal Petroleum rose by 2.98% after it published results from its latest drilling campaign in Ukraine.
In this weekly summary, Mark Watson-Mitchell updates his readers on previous company profiles and other news of interest from the exciting world of small cap stocks…
Even Tory loyalists admit that the UK mortality figures are dire and the economic consequences of lockdown are grave – but Victor Hill refuses to blame Boris Johnson.
The price of shares in FTSE 100 firm Intertek climbed by 8.54% despite its reporting a 4.6% drop in revenues for the first four months of 2020.